Immunoscore Signature Predicts Postoperative Survival and Adjuvant Chemotherapeutic Benefits in Esophageal Squamous Cell Carcinoma.
Lingdun ZhugeBinhao HuangJuntao XieZhendong GaoDifan ZhengShanbo ZhengJiaqing XiangJie ZhangPublished in: Cancer management and research (2020)
The immunoscore was an effective prognostic predictor in ESCC for patients undergoing surgical resection and receiving ACT.